Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy. Randomised Controlled Study

NCT03391830 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03391830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03391830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy. Randomised Controlled Study
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2018
Completion date
January 1, 2020
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aki, ascorbic acid, contrast-induced nephropathy, statin